Welcome to Metabogen

A better public health

As a pioneering company addressing the microbiome to understand health and disease, MetaboGen is creating breakthrough opportunities to develop novel therapeutics and next generation probiotics.

  • Metabogen
    Technology

    MetaboGen has built a platform that integrates top-of-the line metagenomic data analysis with strain identification and subsequent development as well as clinical programs, to ensure successful development of novel assets.

  • Pharmaceutical
    Industry

    By using our platform, we provide great opportunities for integrating metagenomic analysis into translational parts of pharmaceutical development.

  • Next Generation
    Probiotics

    Thorough investigation of the microbiome and identification of bacterial strains provides the probiotic industry with new tools for more precise product development.

Platform

As a pioneering company addressing the microbiome to understand health and disease, MetaboGen is creating breakthrough opportunities to develop novel therapeutics and next generation probiotics. The company was founded based on world leading science from the labs of Professor Fredrik Bäckhed and Professor Jens B Nielsen, to provide commercial access to metagenome research and development. MetaboGen has built a platform that integrates top-of-the line metagenomic data analysis with strain identification and subsequent development as well as clinical programs, to ensure successful development of novel assets.